| 2026-08-12 | Press release | Niagen Bioscience to Present at the 17th Annual Midwest IDEAS Investor Conference |
| 2026-08-06 | Press release | Niagen Bioscience Launches Tru Niagen on Walmart.com, Expanding Access and Diversifying Its E-commerce Marketplace Prese |
| 2026-08-04 | Press release | Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results |
| 2026-08-04 | Earnings deck | Presentation |
| 2026-08-03 | Press release | Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168 |
| 2026-07-28 | Press release | Niagen Bioscience Announces a Newly Published Analysis of Past Clinical Studies Demonstrating Niagen® (Patented Nicotina |
| 2026-07-27 | Press release | Niagen Bioscience to Present at Canaccord Genuity’s 46th Annual Growth Conference |
| 2026-07-21 | Press release | Niagen Bioscience to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026 |
| 2026-07-16 | Press release | Niagen Bioscience Appoints Abhijit Kale, Ph.D., as Senior Director of Global External Research |
| 2026-07-15 | Presentation | Presentation Open Event Link, PDF file, July 15, 2026, (opens in new window) |
| 2026-07-15 | Press release | Niagen Bioscience CEO Rob Fried to Participate in Virtual Fireside Chat to Discuss Pharmaceutical Strategy on July 15, 2 |
| 2026-07-13 | Press release | Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orp |
| 2026-07-09 | Press release | Download , Niagen Bioscience CEO Rob Fried to Participate in Virtual Fireside Chat to Discuss Pharmaceutical Strategy on |
| 2026-07-08 | Press release | Niagen Bioscience Launches Pharmaceutical Program for Accelerated Aging and Rare Genetic Diseases |
| 2026-06-11 | Press release | Niagen Bioscience to Present at the 16th Annual East Coast IDEAS Investor Conference |
| 2026-06-03 | Press release | Download , Niagen Bioscience to Present at the 16th Annual East Coast IDEAS Investor Conference, June 3, 2026, (opens in |
| 2026-06-02 | Press release | Niagen Bioscience Renames ChromaDex External Research Program to the Niagen Research Program, Strengthening Position as |
| 2026-05-08 | Press release | Download , Niagen Bioscience Announces Participation in Upcoming Investor Conferences, May 8, 2026, (opens in new window |
| 2026-05-06 | Press release | Press Release |
| 2026-05-06 | Fact sheet | Download
Our Corporate Fact Sheet |
| 2026-05-06 | Earnings deck | Presentation
of Q1 2026, PDF file, (opens in new window) |
| 2026-05-06 | Press release | Download
(opens in new window) |
| 2026-05-04 | Press release | Niagen Bioscience Launches Niagen Plus Telehealth Platform, Unveiling At-Home Injection Kit Offering |
| 2026-04-28 | Press release | Download , Niagen Bioscience Adds Olympia Pharmaceuticals to 503B Compounding Partner Network for Niagen Plus™, April 28 |
| 2026-04-22 | Press release | Niagen Bioscience to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026 |
| 2026-04-09 | Press release | Download , Niagen Bioscience Collaborates with USP to Establish First-Ever USP Monograph for Nicotinamide Riboside Chlor |
| 2026-03-31 | Press release | Download , Niagen Bioscience Announces First Cruise Ship Clinic Partnership with OneSpaWorld, Bringing the NAD-Boosting |
| 2026-03-19 | Press release | Download , Niagen Bioscience Increases Share Repurchase Program to $20 Million, March 19, 2026, (opens in new window) |
| 2026-03-18 | Press release | Download , Niagen Bioscience to Present at the 38th Annual ROTH Conference, March 18, 2026, (opens in new window) |
| 2026-03-17 | Press release | Niagen Bioscience Surpasses 300 External Research Agreements from Leading Global Institutions on Niagen®, Contributing t |
| 2026-03-10 | Press release | Niagen Bioscience Launches Niagen® Skincare Innovation Lab and Debuts Dermatologist-Tested Niagen NanoCloud™, From Tru N |
| 2026-03-04 | Press release | Niagen Bioscience Reports 30% Year-Over-Year Net Sales Increase to $129.4 million, 103% Net Income Increase to $17.4 mil |
| 2026-03-04 | Earnings deck | Download PDF (opens in new window) |
| 2026-02-26 | Press release | Download , Niagen Bioscience to Streamline and Focus its Operations with the Sale of ChromaDex Reference Standards Busin |
| 2026-02-25 | Press release | Niagen Bioscience Secures New U.S. Patent Covering Intravenous and Injection Formulations and Methods of Use for Nicotin |
| 2026-02-20 | Presentation | State of the Science February 2026
(opens in new window) |
| 2026-02-09 | Press release | Download , Niagen Bioscience is the Premiere Sponsor of the Inaugural “NAD for Health: Opportunities & Challenges” Confe |
| 2026-02-06 | Press release | Download , Niagen Bioscience to Report Fourth Quarter and Full Year 2025 Financial Results on Wednesday, March 4, 2026, |
| 2026-01-15 | Press release | Niagen Bioscience Expands HSA/FSA Access for Tru Niagen®, the Leading NAD+ Supplement in the U.S.* |
| 2025-06-09 | Press release | Press Release |